| “In
1997, we put HSV1716, the virus we developed for cancer therapy,
into the brain of a patient with ‘recurrent glioma’,
a deadly form of brain tumour, who had been given 4 months to
live. This event was a world first and was the fruition of many
years of fundamental research and determination to translate
from “the bench to the patient”. The fact that he
is still alive and well in 2005 is an added bonus and makes
me even more determined to push forward this approach to cancer
therapy” Professor
S. Moira Brown
Chief Scientist, Crusade Labs
|
